- You can view the full Valeant Pharmaceuticals International Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Jim Cramer ponders the presidential campaign tradition of corporate bashing and how the stock market is more important than the Fed.
While the public seized on Mylan's price increases for EpiPens, the story of a common drug industry practice - increasing prices ahead of generics entering the market - got lost.
Valeant (VRX) stock was trading higher this morning after bullish comments at Morgan Stanley.